Skip to main content
Signal8

Veradigm Inc. (MDRX)

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform. The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency. Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology. The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.

Sector: Services-Computer Integrated Systems Design

Industry: Medical - Healthcare Information Services

Veradigm Inc. logo

Veradigm Inc.

OTC:MDRXHealthcare
-4.04%$4.75
Mkt Cap$517.71M
Float105.95M
O/S108.99M
Inst Own0.0%
SI0.5%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$517.71M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.01%

based on 108.99M shares outstanding

SectorHealthcare
IndustryMedical - Healthcare Information Services
ExchangeOTC
CountryUSUS
IPO DateJul 26, 1999
Shares Outstanding108.99M
Float105.95M
Company Overview

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform.

The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency.

Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology.

The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.

Leadership

Carol J. Zierhoffer

Director

Dave B. Stevens

Director

Elizabeth A. Altman

Director

Jonathan J. Judge

Director

Employees

2K+

Country

US

Sector

Healthcare

Website

veradigm.com

Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
No price targets available
Ratings Distribution
BUY
16
HOLD
24
SELL
3
TOTAL43
Insider Trades
InsiderTypeShares
ASAR VINIT K profile photoASAR VINIT KGrant/Award42.5K
Zierhoffer Carol J profile photoZierhoffer Carol JGrant/Award42.5K
Rodriguez Susan profile photoRodriguez SusanGrant/Award42.5K
SILVERMAN LOU profile photoSILVERMAN LOUGrant/Award42.5K
Greyenbuhl Christian profile photoGreyenbuhl ChristianGrant/Award318.8K
Stevens David B profile photoStevens David BGrant/Award42.5K
Shareholders
0.0%
Institutional
(2)
4.2%
Insiderⓘ
(16)
11.5%
5%+ Owners
(2)
84.3%
Unattributed (incl. retail)ⓘ
Institutional0.0%
Insider4.2%
5%+ Beneficial11.5%
Unattributed (incl. retail)84.3%
Sources: 13F, Form 4, 13D/13GO/S: 109.0M · as of 12 May 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$3.25$6.00
$4.75(55th percentile)
Volume
Average Daily Volume97.09K
502.30K today vs 97.09K avg(+417%)

30d Avg

97.09K

60d Avg

99.79K

90d Avg

83.97K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...